SCHEMBL21292769

SCHEMBL21292769

O=C(N/N=C/c1cc([N+](=O)[O-])ccc1O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.86

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 2/20 0.82
KDM4E B2RXH2 11/20 0.82
MAPT P10636 10/20 0.82
TDP1 Q9NUW8 6/20 0.82
ALDH1A1 P00352 3/20 0.82
L3MBTL1 Q9Y468 1/20 0.82
MEN1 O00255 8/20 0.72
KMT2A Q03164 8/20 0.72
HTT P42858 4/20 0.72
LMNA P02545 3/20 0.72
SMN1; SMN2 Q16637 1/20 0.72
POLB P06746 1/20 0.68
DUSP3 P51452 1/20 0.65
PTPN5 P54829 1/20 0.65
PTPN11 Q06124 1/20 0.65
NPC1 O15118 2/20 0.64
CCR6 P51684 1/20 0.63
NPSR1 Q6W5P4 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292771 1.00 PHGDH (0.82) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292819 0.95 PHGDH (0.79) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL16035055 0.95 PHGDH (0.79) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292675 0.94 PHGDH (0.81) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292677 0.94 PHGDH (0.81) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292662 0.93 PHGDH (0.76) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292753 0.93 PHGDH (0.76) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292664 0.93 PHGDH (0.76) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292827 0.93 PHGDH (0.76) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292807 0.93 PHGDH (0.76) PHGDHKDM4EMAPTTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.